nafuril 2 2mg tablets
delorbis pharmaceuticals ltd (0000009620) 17 athinon street, ergates industrial area, lefkosia, 2081, 28629 - glimepiride - tablets - 2mg - glimepiride (0093479971) 2mg - glimepiride
nafuril 3 3mg tablets
delorbis pharmaceuticals ltd (0000009620) 17 athinon street, ergates industrial area, lefkosia, 2081, 28629 - glimepiride - tablets - 3mg - glimepiride (0093479971) 3mg - glimepiride
nafuril 4 4mg tablets
delorbis pharmaceuticals ltd (0000009620) 17 athinon street, ergates industrial area, lefkosia, 2081, 28629 - glimepiride - tablets - 4mg - glimepiride (0093479971) 4mg - glimepiride
solu-medrone 125mg/vial powder & solvent for solution for injection
pfizer hellas ae (0000003442) 243 messoghion avenue, neo psychiko, athens, 15451 - methylprednisolone sodium succinate - powder & solvent for solution for injection - 125mg/vial - methylprednisolone sodium succinate (0002375033) 165,8mg
solu-medrone 1000mg/vial powder & solvent for solution for injection
pfizer hellas ae (0000003442) 243 messoghion avenue, neo psychiko, athens, 15451 - methylprednisolone sodium succinate - powder & solvent for solution for injection - 1000mg/vial - methylprednisolone sodium succinate (0002375033) 1328mg
plenur 400mg modified-release tablet
faes farma sa (0000002088) maximo aquirre 14, leioa(vizcaya), 48940 - lithium carbonate - modified-release tablet - 400mg - lithium carbonate (0000554132) 400mg
trevusin 4mg capsule,hard
delorbis pharmaceuticals ltd (0000009620) 17 athinon street, ergates industrial area, lefkosia, 2081, 28629 - silodosin - capsule,hard - 4mg - silodosin (0160970547) 4mg
trevusin 8mg capsule,hard
delorbis pharmaceuticals ltd (0000009620) 17 athinon street, ergates industrial area, lefkosia, 2081, 28629 - silodosin - capsule,hard - 8mg - silodosin (0160970547) 8mg
ontilyv
bial portela & companhia s.a. - opicapone - Νόσος του Πάρκινσον - Αντιπαρκινσονικά φάρμακα - ontilyv is indicated as adjunctive therapy to preparations of levodopa/ dopa decarboxylase inhibitors (ddci) in adult patients with parkinson’s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.